Subject Areas on Research
- Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.
- How Well Do Rheumatology Fellows Manage Acute Infusion Reactions? A Pilot Curricular Intervention.
- Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.